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Abstract
HIV/AIDS remains the second most common cause of death in low and middle-income
countries (LMICs), and only 34% of eligible patients in Africa received antiretroviral therapy
(ART) in 2013. This study investigated the impact of ART decentralization on patient enroll-
ment and retention in rural Malawi. We reviewed electronic medical records of patients reg-
istered in the Neno District ART program from August 1, 2006, when ART first became
available, through December 31, 2013. We used GPS data to calculate patient-level dis-
tance to care, and examined number of annual ART visits and one-year lost to follow-up
(LTFU) in HIV care. The number of ART patients in Neno increased from 48 to 3,949 over
the decentralization period. Mean travel distance decreased from 7.3 km when ART was
only available at the district hospital to 4.7 km when ART was decentralized to 12 primary
health facilities. For patients who transferred from centralized care to nearer health facilities,
mean travel distance decreased from 9.5 km to 4.7 km. Following a transfer, the proportion
of patients achieving the clinic’s recommended4 annual visits increased from 89% to
99%. In Cox proportional hazards regression, patients living8 km from a health facility had
a greater hazard of being LTFU compared to patients <8 km from a facility (adjusted HR:
1.7; 95% CI: 1.5–1.9). ART decentralization in Neno District was associated with increased
ART enrollment, decreased travel distance, and increased retention in care. Increasing
access to ART by reducing travel distance is one strategy to achieve the ART coverage and
viral suppression objectives of the 90-90-90 UNAIDS targets in rural impoverished areas.
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Introduction
HIV/AIDS remains a leading cause of death and disability, with over 35 million people
infected worldwide, resulting in 1.5 million deaths annually [1]. Although the Millennium
Development Goals aimed for universal access to antiretroviral therapy (ART) by 2010 [2], in
2013, only a third of those eligible for ART living in low- and middle-income countries
(LMICs) received it [3,4]. In Africa, an estimated 66% of eligible people living with HIV were
not receiving ART in 2013 [5].
In order to increase access to HIV treatment, many countries in Sub-Saharan African
(SSA) have decentralized HIV care from hospitals to health centers and other primary health
facilities closer to the community [6]. Decentralization seeks to reduce distance traveled by
patients, task shift ART initiation and HIV management from physicians to lower-cadre health
workers, and integrate delivery of ART within existing primary health care systems.
Malawi, a country of over 16 million people with an adult HIV prevalence of 10% and 84%
of its population living in rural areas, has prioritized ART decentralization, achieving ART
coverage levels of 80% in 2013 [7–9]. Neno District is one of the most impoverished and geo-
graphically isolated regions of Malawi. In Neno District, universal HIV testing became avail-
able in 2007, and ART care was decentralized from one district hospital to 12 health facilities
between 2006 and 2012, with nurses and non-physician clinicians assuming primary responsi-
bility for ART service delivery.
In Malawi and elsewhere in SSA, ART decentralization has generally improved outcomes
[6,10]. Implementation studies from Malawi, South Africa, and Ethiopia have demonstrated
that decentralization leads to improved patient retention and enrollment [10], [11], particu-
larly for stable adult patients on ART [12]. Decentralization has also been shown to reduce
costs by shifting care to lower-level professionals [13], and to improve access to care for popu-
lations from lower socioeconomic strata [14].
Despite the available evidence, gaps remain in our understanding of the effects of initiating
ART at decentralized facilities [6,10,15] and the associations between this kind of full decen-
tralization and longitudinal changes in patient behavior and health outcomes [10]. To address
these evidence gaps, we used a geographic information system (GIS) and an electronic medical
record (EMR) to track changes in patients’ travel distance, treatment-seeking behavior, and
care retention from 2006 to 2013 during ART decentralization in rural Neno District, Malawi.
Materials and methods
ART decentralization and service delivery in Neno
We conducted our study in Neno District, Malawi, a mountainous rural region of 1469 km2 in
the south of the country with a 2013 population of approximately 137,000 people [16]. In 2007,
Partners In Health/Abwenzi Pa Za Umoyo (PIH/APZU) began a partnership with the Ministry
of Health (MOH) to provide comprehensive, community-based health care in Neno District.
PIH/APZU utilizes an accompaniment model to pair community health workers with persons
living with HIV (PLWH), which has successfully promoted patient retention and favorable
clinical outcomes in several resource-constrained settings, including Neno [17,18]. Between
2006 and the end of 2012, the MOH opened 10 static ART clinics supported by PIH/APZU at
primary health facilities throughout the district to decentralize front-line HIV care (Fig 1).
When new ART clinics opened, all patients were invited to transfer to an ART clinic closer to
their home.
HIV treatment at Neno District facilities followed national guidelines [19,20]. From 2006 to
2010, HIV-infected patients were ART eligible if they met one of the following criteria: CD4
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count<250 cells/mm3, WHO Stage 3 or 4 disease, or Stage 2 disease with a total lymphocyte
count<1,200 cells/ mm3. In 2011, Malawi introduced the following new guidelines: an
increased CD4 count threshold for ART initiation (350 cells/mm3); initiation of universal life-
long ART for all HIV-infected children under 2 years; and Option B+, which included lifelong
ART for all HIV-infected pregnant and breastfeeding women. Patients who initiated ART vis-
ited a health facility every 1–3 months for medical review and to refill their supply of cotrimox-
azole preventative therapy and ART.
Study design and population
We performed a retrospective cohort study of all adult and pediatric patients living in Neno
District who initiated ART between August 1, 2006 and December 31, 2013 at any clinic in the
district and had at least two ART visits in this time period.
Data source
Malawi’s national HIV program uses a paper-based reporting system to collect data on patient
demographics and service provision. In Neno, PIH/APZU augments the MOH system by tran-
scribing the paper patient data into equivalent electronic forms in an electronic medical record
(EMR) using the OpenMRS platform [21]. To monitor and ensure EMR data fidelity the PIH/
APZU informatics team operated a data quality assessment system. It included logic checks
built into EMR, automated data quality reports, and routine cross-referencing of aggregate
EMR data. Key indicators were reviewed on weekly, monthly and quarterly bases, including
the quarterly Malawi Ministry of Health HIV program data audit reports. In addition, a closed
feedback loop between the clinics and the EMR was enforced to ensure that findings were
shared in a timely manner in both directions. We exported individual-level data, including
health facility visit records, and ascertained patient transfers between health facilities using a
unique EMR identifier.
Fig 1. ART decentralization timeline. The timeline displays HIV care in Neno District from August 1, 2006, when public care first became
available, through December 31, 2012. (DH = district hospital, CH = community hospital, HC = health center, RHC = rural health center).
https://doi.org/10.1371/journal.pone.0185699.g001
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Geospatial data collection and analysis
We collected GPS coordinates with a GPSMAP 60CSx device (Garmin, Olathe, Kansas, USA)
for each Neno health facility and each village recognized by the government of Malawi. To
ensure patient privacy and simplify the data collection process, we collected coordinates at the
commercial center of each village, or if no commercial center existed, at the home of the village
chief. GPS coordinates were converted to a shapefile using DNR Garmin version 6. For each
patient, we linked their home village reported at ART registration to corresponding GPS coor-
dinates. In our analyses, we excluded patients with missing village information.
For travel distance analyses, we used both Euclidean distance and cost distance. Euclidean
measurements calculated distance “as the crow flies”, without regard to topography. Cost dis-
tance considered topographical features when calculating distance between two points. To cal-
culate cost distance, we weighted travel distance by topographical slope. The cost distance
between two points was minimum weighted distance between two points. Distance analyses
were performed in ArcMap 10.2 and Python 2.7.
Statistical analysis
To analyze the impact of full ART decentralization, we divided Neno district’s decentralization
process into five phases based on the following rationale: during phase 1 ART was available
only at the Neno District Hospital; in phase 2 the Lisungwi Community Hospital began to pro-
vide ART. During phases 3 and 4, ART became available at primary health facilities, with 4
facilities providing ART during phase 3 and an additional 6 during phase 4. Phase 5 captured
the six-month period immediately following full ART decentralization (Fig 1). The ends of the
first three phases (31 May 2008, 31 January 2009, and 31 July 2010) correspond to the day
prior to the opening of a hospital or clinic in the next wave of service decentralization. The
fourth phase ended on 30 April 2012, six months after the final health facility began providing
HIV treatment, and the final phase ended on 31 October 2012, 6 months thereafter. The fourth
phase also captured the 2011 introduction of Option B+ and guideline shift.
Our primary outcome measures were appointment adherence and loss to follow up.
Appointment adherence is thought to provide a measure of patient engagement in HIV care,
and may predict viral suppression [22,23]. Because the EMR lacked consistent information on
the quantity of ARVs dispensed at each visit (which varied from a one- to three-month sup-
ply), we were unable to calculate when the patient’s next visit should occur. Instead we esti-
mated appointment adherence by applying the MOH guideline that all patients have at least 4
visits per year, suggesting that those with fewer visits would have experienced ART interrup-
tion. Therefore, we conservatively calculated the median number of visits per year for each
patient, and defined patients with fewer than 4 visits per year to be “non-adherent” to
appointments.
We defined a patient as “lost to follow up (LTFU)” if his or her EMR status was not “alive
and on ART.” This included patients whose vital status was recorded as dead, defaulted,
stopped or transferred out (without a corresponding “transfer in” to a different facility) or if
the patient did not have1 recorded ART visit with 180 days of the relevant time point, a mea-
sure of LTFU previously validated in SSA [24]. We included death and default within our defi-
nition of LFTU to account for previously described high mortality among patients who leave
care in SSA [25]. However, due to our inability to track people who transferred outside of the
district who may have received care, this approach likely resulted in a conservative estimate of
patient retention. Non-LTFU patients were considered “active.”
We report descriptive statistics for patients organized by decentralization phase, including
the number of patients enrolled in care at any point during each phase, as well as the number
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of patients newly enrolled during each phase. We describe the sub-cohorts of patients that
newly initiated ART for each phase and present their demographic, clinical, and distance
information. We defined a patient as “in care” at the end of a phase if his/her most recent doc-
umented status prior to the end of the phase was “alive and on ART” and if he/she had1
ART visit within 180 days of the phase date [24].
We examined changes in appointment adherence and LTFU one year after enrollment
before and after transfer in the subgroup of patients who transferred at least once during the
study period, matched by patient (before/after transfer), with repeated measures analysis of
variance (ANOVA). We also used t-tests to compare demographic characteristics, annual visits
and LTFU between patients who transferred and those who never transferred.
Finally, to assess the association between travel distance and LTFU, we used Cox propor-
tional hazards regression to estimate the hazard ratio associated with being LTFU as a function
of travel distance. We dichotomized travel distance to care at 8km based on Malawi’s defini-
tion of access to care [26] and treated it as a time-varying covariate to control for length-biased
sampling, i.e. that patients closer to care were often enrolled for longer periods of time [27,28].
We estimated unadjusted odds ratios and odds ratios adjusted for potential confounders, all of
which remained constant over time, except for whether a patient had transferred in a particu-
lar enrollment period. Statistical analyses were performed in R 3.1.0.
Ethics statement
The Partners Healthcare Human Research Committee, USA (Protocol #: 2014P001460) and
the National Health Sciences Research Committee of Malawi (Protocol #: 1216) granted ethical
approval for this study.
Results
Overall, 5,969 unique patients enrolled into ART care at a Neno District health facility between
August 1, 2006 and November 1, 2012, and attended at least 2 visits. Of these patients, 753
(13%) reported home villages outside of Neno District, 301 (5%) were missing valid village
information, and 50 (<1%) lived in Neno District villages for which we lacked GPS data.
Therefore, 4,865 unique patients (82%) ever enrolled in the ART program on or before
November 1, 2012 with at least 2 visits, 1,074 (22%) of whom transferred from one health facil-
ity to another at least once during the study period.
Phase analysis
Active patient enrollment increased from 535 patients at the end of phase 1 to 3,949 patients at
the end phase 5 (Table 1, Fig 2). During phases 3 and 4, as additional ART facilities opened,
most patients new to these facilities were new ART enrollees. However, 11% of patients trans-
ferred during phase 3 (n/N = 257/2,289) and 27% (n/N = 978/3,595) in phase 4. During phase
5 with decentralization complete, the percentage of transfers decreased to 2% (n/N = 91/
3,949).
Mean patient age at ART initiation was 33 years, and approximately two-thirds (64%) of
patients were female. There was no evidence that age at initiation or patient gender varied by
phase (p> 0.1 for all comparisons). Over time, greater proportions of patients initiated ART
for less clinically advanced HIV disease; the percentage of patients who had initiated ART at
WHO stage 3 or 4 decreased from 73% in phase 1 to 44% in phase 5 (p< .001).
At the end of phase 1, patients lived an average of 7.3 km from their ART facility, and 49%
of patients lived beyond 8 km of their ART facility, not meeting the Malawi MOH’s definition
of access to a health facility [26] (Table 1). This percentage decreased significantly over time to
Decentralization of ART in Neno, Malawi
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38% at the end of phase 3 (p< 0.001) and 20% at the end of phase 5 (p< 0.001), as average dis-
tance to the ART clinic decreased to 4.7 km (p< 0.001). Mean cost distance to ART clinic,
which considered topography in the distance calculation, decreased from 18.8 km at the end of
phase 1 to 7.9 km at the end of phase 5 (p< 0.001). The proportion of patients with fewer than
4 visits per year ranged from 6% in phase 2 to 1% in phases 4 and 5 (p< .001). Overall, 83% of
patients were retained in care for at least one year with minimal variability across phases.
Transfer analysis
One thousand seventy-four patients (22%) transferred ART facilities at least once (Table 2).
Sixty-eight percent (n/N = 731/1,074) of transfers were women. Mean travel distance
decreased from 9.5 kilometers to the patient’s pre-transfer facility to 4.7 kilometers for her
Table 1. Demographic, clinical, and distance-to-care for patient cohorts during each phase of full decentralization.
Phase 1 Phase 2 Phase 3 Phase 4 Phase 5
Start of phase 1-Aug-06 1-Jun-08 1-Feb-09 1-Aug-10 1-May-12
End of phase 31-May-08 31-Jan-09 31-Jul-10 30-Apr-12 31-Oct-12
Demographic information
Health facilities providing ART 1 2 6 12 12
Number of patients ever enrolled during phase 574 1103 2575 4072 4200
Number of patients at end of phase1 (%) 535 (93) 996 (90) 2289 (89) 3595 (88) 3949 (94)
Women (%) 359 (67) 651 (65) 1487 (65) 2383 (66) 2623 (67)
Mean age at ART initiation (sd) 32.5 (13.9) 32.5 (14) 33.2 (14.3) 33 (13.8) 33.2 (13.8)
Number of transfers during phase (%)2 0 (0) 3 (<1) 257 (11)*** 978 (27)*** 91 (2)***
Clinical information
Patients who started ART at WHO stage 3 or
4 (%)3
389 (73) 630 (63)*** 1225 (54)*** 1630 (45)*** 1748 (44)***
Median clinic visits per patient per year (IQR) 6.2 (5 to 7) 6.1 (5 to 7) 6.5 (6 to 8)*** 7.3 (6 to 9)*** 7.6 (6 to 9)***
Patients with < 4 clinic visits per year (%) 27 (5) 59 (6) 85 (4) 19 (1)*** 15 (<1)***
1-year retention of new patients enrolled
during phase (%)4
491 (86) 453 (81) 1234 (82)* 1442 (84) 404 (82)
Distance
Mean travel distance to facility in km (sd)5 7.3 (5.4) 7.5 (5.3) 6.3 (4.1)*** 4.7 (4.1)*** 4.7 (4.1)***
Patients greater than 8 km (Euclidian) (%) 260 (49) 502 (50) 876 (38)*** 717 (20)*** 774 (20)***
Patients attending closest health facility (%)6 535 (100) 969 (97)*** 1922 (84)*** 2117 (59)*** 3058(77)***
Mean cost travel distance in km (sd)7 18.8(15.7) 16.6(15.8)* 10.9 (11.9)*** 7.8 (9.5)*** 7.9(9.6)***
* p < .05,
** p < .01,
*** p < .001;
all comparisons made to Phase 1
1 Patients from Neno District enrolled in care at end of phase. All estimates exclude patients receiving care at Neno facilities, but residing outside of Neno
District.
2 Patients who transferred from one Neno District clinic health facility to another Neno District clinic health facility during phase. The denominator was
number of patients ever enrolled during phase.
3 19% of observations were missing WHO stage at ART initiation.
4 1-year retention of all patients who first enrolled at any Neno health facility during the phase.
5 Mean Euclidean distance from patient’s home village to health facility where ART care was received. (km)
6 A patient attended the nearest health facility if she was enrolled at the facility that was the minimum Euclidean distance from the center of her home village.
7 Mean cost distance from patient’s home village to health facility where ART care was received (km)
https://doi.org/10.1371/journal.pone.0185699.t001
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final facility (p< 0.001), and the percentage of individuals living within 8 km of their health
facility increased from 30% to 81% (p< 0.001). Moreover, the proportion of individuals with
<4 visits per year decreased from 11% for the initial facility to 1% for the post-transfer facility
(p< .001).
We also compared patients who experienced at least one transfer (i.e. “transfers”) to those
who were only enrolled at one facility during their time in care (i.e. “non-transfers”) (Table 2).
Patients who transferred tended to have more severe disease (52% with WHO stage 3 or 4
versus 33% in non-transfers). Only 45 (1%) of non-transfer patients had<4 visits per year,
similar to transfer patients at their final facility, also 1.0% per year (p = 0.6). Non-transfers
traveled a mean of 5.1 km, similar to the average of 4.7 km traveled by transfers to their final
facility (p = .004). However, non-transfer patients were more likely to be LTFU at 1 year (17%)
than transfer patients (1%; p< 0.001).
Distance analysis
In our univariate analysis (n = 6014 enrollment periods of 4865 patients), the hazard ratio
associated with living>8 km from a health facility compared to8 km from a health facility
Fig 2. Map of decentralization of ART services from 2008 to 2012. Crosses show location of health facilities. Dots show number of ART
patients by home village, color-coded by health facility patient attended. Larger dots indicate a larger number of patients.
https://doi.org/10.1371/journal.pone.0185699.g002
Decentralization of ART in Neno, Malawi
PLOS ONE | https://doi.org/10.1371/journal.pone.0185699 October 3, 2017 7 / 13
was 1.70 (95% CI: 1.5–1.9) (Table 3). In multivariate analysis (Table 3), we controlled for possi-
ble confounders, including gender, age, and transfer status. We obtained a nearly identical
hazard ratio associated with living >8 km from a health facility (aHR = 1.68, 95% CI: 1.5–1.9).
Including WHO stage at ART initiation (n = 3,445) did not substantially impact the estimate
of the effect of travel distance on LTFU (aHR = 2.27, 95% CI: 1.8–2.8) (S3 Table).
Discussion
Employing the first application of geospatial data, to our knowledge, to quantify the relation-
ship between patient-level travel distance to ART services and patient outcomes, we examined
the impact of ART decentralization on travel distance, appointment adherence, and LTFU in a
rural setting in SSA. We observed that ART decentralization was associated with increased
patient enrollment, reduced patient travel distance, and decreased LTFU.
Though HIV testing and counselling (HTC) was available at all Neno health facilities begin-
ning in mid-2007, many patients meeting ART eligibility criteria did not begin ART until their
local facility offered it. In 2008, the patient home village distribution was highly concentrated
around the only facility offering ART. By 2012, when ART was available at all 12 facilities in
the district, the home village distribution of ART patients corresponded roughly to the general
population distribution. Furthermore, 80% of patients in Neno traveled less than 8 km to
reach their chosen facility. Among patients who transferred to a closer facility after having pre-
viously received ART at another facility located further away, the percentage with poor
appointment adherence decreased from 11% to 1% after transfer. Proximity to ART care
Table 2. Comparison of demographic, clinical and distance data for transfers and non-transfers.
Transfers Non-Transfers
First Facility Final Facility1 Facility2
Demographic information
Number of patients 1074 1074 3791
Women (%) 731 (68) 731 (68) 2359 (62)***
Mean age at ART initiation (sd) 31.8 (14.5) 31.8 (14.5) 33.6 (13.9)***
Clinical information
Patients starting ART at WHO stage 3 or 4 (%)3 557 (52) 557 (52) 1235 (33)***
Median clinic visits per year (IQR) 6.7 (5.1–9.2) 6.6 (5.8–8.3) 8.3 (6.7–10.5)***
Patients with <4 visits per year (%) 123 (11) 11 (1)*** 45 (1)
LTFU at 1 year (%)4 15 (1) 15 (1) 652 (17)***
Distance
Mean travel distance to facility, km (sd)5 9.5 (4.6) 4.7 (4.4)*** 5.1 (4.5)**
Patients within 8 km (Euclidean) (%) 322 (30) 874 (81)*** 2868 (76)***
Mean cost travel distance in km (sd)6 19.7 (16) 9.6 (11.4)*** 8.4 (10.8)**
* p < .05,
** p < .01,
*** p < .001
1 Asterisks indicate comparisons between transfers at their first facility and the same patients receiving ART at their final facility (repeated-measures
ANOVA/Wilcox test for medians)
2 Asterisks indicate comparisons between patients who never transferred (non-transfers) and transfers at final facility (ANOVA/Wilcox test for medians)
3 Data were missing for 292 transfers at first facility, 229 transfers at final facility, and 1234 non-transfers.
4 Patients alive and in care at any Neno health facility one year after enrollment
5 Mean Euclidean distance from patient’s home village to health facility where ART care was received (km)
6 Mean cost distance from patient’s home village to health facility where ART care was received (km)
https://doi.org/10.1371/journal.pone.0185699.t002
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appeared to be a key driver for treatment initiation and adherence in this rural African popula-
tion with little access to motorized transportation.
Previous studies from Malawi have demonstrated conflicting results about the effects of
ART decentralization on patient outcomes. In rural Thyolo District, although the incidence of
patient LTFU was significantly lower for patients started on ART at primary health facilities
compared to those initiating ART at the district hospital, ART decentralization was associated
with higher patient mortality [11]. In Zomba District, patients receiving decentralized care
were 40% less likely to experience LTFU and death during the 10 month study period but the
study included a relatively healthy population [29]. Our results suggest that full ART decentral-
ization for all patients can achieve favorable results in Malawi and similar impoverished rural
SSA regions, and may help achieve the ART provision and viral suppression targets of the 90-
90-90 UNAIDS Declaration.
We detected differences in LTFU between ART enrollees who transferred facilities, often
enrolling in earlier phases, and later enrollees who initiated ART once a nearby facility began
offering treatment. Eighty-three percent of patients who did not transfer were retained in care
for at least 1 year, compared to 99% of transfers, despite similar average travel distances. We
hypothesize that patients who enrolled in ART earlier, when ART facilities were more limited,
were generally a more adherent population. Nevertheless, we found strong evidence that
shorter travel distance was associated with lower LTFU for both transfers and non-transfers.
The major strength of this study resides in our ability to examine the longitudinal relation-
ship between individual patients’ distance to care and ART treatment outcomes. Previous
research has typically divided patients into those receiving care at centralized facilities and
those receiving care at decentralized facilities, without the ability to detect patient-level varia-
tions in travel time [6,29,30]. While some studies have investigated travel time for HIV patients
Table 3. Association between travel distance to care and hazard of loss to follow up (LTFU), and exploratory analysis of association between
patient covariates and LTFU.
Unadjusted HR (95% CI) Adjusted HR (95% CI)1
Travel distance2
< 8km 1.00 (Ref) 1.00 (Ref)
 8km 1.70 (1.51–1.91)*** 1.68 (1.49–1.89)***
Age (years)3 1.00 (1.00–1.01) 1.00 (0.995–1.00)
Gender
Female 1.00 (Ref) 1.00 (Ref)
Male 1.64 (1.46–1.84)*** 1.62 (1.44–1.82)***
Transfer4
No 1.00 (Ref) 1.00 (Ref)
Yes 1.05 (0.87–1.28) 1.11 (0.91–1.34)
Cox proportional hazards regression (n = 6014 enrollment periods of 4865 patients): primary outcome variable was loss to follow up. Travel distance and
transfer were treated as time-varying covariates; other covariates remained constant over time.
* p < .05,
** p < .01,
*** p < .001
1 Adjusted for all other variables in table
2 Euclidean distance from patient’s home village to health facility where ART care was received; measured as a time-varying covariate based on a patient’s
location during a particular time interval
3 Age at ART initiation, centered at mean
4 Compares patients who had transferred from one Neno health facility to another to those at their first facility, also time-varying.
https://doi.org/10.1371/journal.pone.0185699.t003
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[31,32], these either did not examine patient outcomes, or found little relationship between
travel time and appointment adherence. By contrast, we observed a strong association between
distance to care and LTFU.
Our study had several limitations. First, guideline changes and other secular trends during
the study period may have introduced bias. For example, in 2011, the Option B+ strategy was
introduced nationally resulting in increased ART enrolment of relatively healthy individuals.
In addition, anecdotal evidence suggests that HTC uptake increased in Neno as ART services
became more widely available in newly ART-accredited facilities. As a result, the number of
patients eligible to start ART significantly increased over time, and we were unable to disen-
tangle how decentralized care affected ART enrollment after accounting for these factors. Sec-
ond, changes in the way PIH/APZU provided HIV care during the study period may have
influenced enrolment, adherence, and retention in care. For example, at ART initiation
patients received a supplemental food package and the duration of this food support changed
during the study period. We cannot predict the magnitude or direction of the effects of these
changes in HIV care on our study outcomes; however, the relatively stable one-year retention
proportion of 81–86% over the 5 study phases suggests that these effects may have been mini-
mal. Third, missing clinical information, such as baseline WHO stage, limited our ability to
track changes in our cohort over time, particularly with regard to HIV disease severity and
immunosuppression at ART initiation. Fourth, because Malawi has limited data on subna-
tional HIV trends [33], we were unable to consider ecological trends in HIV prevalence in
Neno.
Our geospatial analysis also had some limitations. As each village had only one GPS point,
we could only approximate each patient’s home location, and because the electronic medical
record did not always denote patient address changes, we were unable to detect all patient
moves. Village data were also missing for approximately 5% of patients. Euclidean distances
do not represent the true distance patients travel to receive care given that footpaths and roads
adapt to terrain. The use of cost distance corrects for elevation changes, but likely still underes-
timates the true distance traveled by patients to reach their health facility. Finally, we were
unable to identify patients who initiated and maintained ART at mobile clinics prior to the
opening of the nearest decentralized ART clinic, which may have overestimated travel
distance.
Nevertheless, we believe that the results of our study are generalizable to other rural settings
in Malawi and elsewhere in SSA. We observed a strong association between ART decentraliza-
tion, decreased patient travel distance, and increased ART enrollment and retention in care.
Our data, derived from a public sector ART program, reflect that full ART decentralization
can improve outcomes even under “real-world” clinical conditions in an extremely impover-
ished, rural district. The use of GIS technology and mathematical modeling can further sup-
port the rational and equitable introduction of additional ART sites in Malawi [34]. As care for
other chronic illnesses is scaled up and decentralized in SSA, it will be useful to assess geo-
graphic access to care and its relationship to treatment adherence and other clinical and ser-
vice-related outcomes.
In conclusion, our findings highlight the benefits of decentralized ART care and the poten-
tial of increasingly robust geographic information systems to improve our understanding of
how distance to health facilities affects LTFU and other outcomes for HIV-infected patients.
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